Dr Chris Tsai
Dr. Chris Tsai (PhD) is a visionary entrepreneur in cell therapy, regenerative aesthetics, genetic diagnostics, and AI-driven EV therapy. As the founder of BIONET Corp., Genetics Generation Advancement, and BIONET Therapeutics, he has established a comprehensive biotech ecosystem spanning mesenchymal stem cell banking, cell therapy, genomic & precision medicine, and exosome-based products.
Dr. Tsai is a prominent advocate for the clinical translation of cell and exosome technologies. His leadership extends across key industry organizations, including:
- President: Precision Medicine Industry Association of Taiwan (PMIA)
- Vice President: Taiwan Bio Industry Organization
- Steering Committee Member: Taiwan Alliance for Extracellular Vesicles (TAEV)
- Global Leadership: Former Vice President & Steering Committee Member of the International Society for Cellular Therapy (ISCT); Founder and former Chairman of the Asia Pacific Cord Blood Bank Consortium (APCBBC).
Recognized for his significant industry contributions, Dr. Tsai is a recipient of the Ernst & Young Entrepreneur of the Year, the Model of Taiwan and Overseas Entrepreneurs, and the 2025 Tatler IMPACT Award. He is an esteemed alumnus of the National Taiwan University Department of Chemical Engineering.
